Showing results (651-660 of 2,347) with videos related to

Sort By:
Pageof 235
Oncogene|May 9, 2007
Complete activation of Bax by a single site mutationH Zhou, Q Hou, J L Hansen, et al.
Homeopathy : the Journal of the Faculty of Homeopathy|January 18, 2007
Outcomes from homeopathic prescribing in veterinary practice: a prospective, research-targeted, pilot studyR T Mathie, L Hansen, M F Elliott, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 21, 1998
Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurementL L Hansen, J Andersen, J Overgaard, et al.
BMJ Case Reports|June 21, 2011
Histopathological findings after retinal endovascular lysis in central retinal vein occlusionNicolas Feltgen, Hansjuergen Agostini, Claudia Auw-Haedrich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
Graft failure and graft nephrectomy without severe complicationsB L Hansen, N Rohr, V Svendsen, et al.
Journal of Animal Science|May 8, 2018
Effects of increasing supplemental dietary Zn concentration on growth performance and carcass characteristics in finishing steers fed ractopamine hydrochlorideOlivia N Genther-Schroeder, Mark E Branine, Stephanie L Hansen
European Journal of Clinical Pharmacology|August 24, 1999
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivoJ T Larsen, L L Hansen, O Spigset, et al.
International Maritime Health|February 21, 2009
Major differences in rates of occupational accidents between different nationalities of seafarersHenrik L Hansen, Lise Hedgaard Laursen, Morten Frydberg, et al.
Klinische Monatsblatter Fur Augenheilkunde|December 1, 1991
[Chronic subgaleal abscess as a cause of eyelid swelling]P Janknecht, T Hammerich, J M Soriano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulationB V Bysted, B Scharling, T Møller, et al.
Pageof 235